Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy
Oncotarget
.
2021 Jan 5;12(1):8-9.
doi: 10.18632/oncotarget.27865.
Authors
Adam M Sonabend
,
Roger Stupp
,
Catalina Lee-Chang
,
Hideho Okada
PMID:
33456708
PMCID:
PMC7800771
DOI:
10.18632/oncotarget.27865
No abstract available
Keywords:
glioblastoma; glioma; immunoediting; immunotherapy; resistance.
Publication types
Editorial
Grants and funding
DP5 OD021356/OD/NIH HHS/United States
P50 CA221747/CA/NCI NIH HHS/United States
R01 NS110703/NS/NINDS NIH HHS/United States
R35 NS105068/NS/NINDS NIH HHS/United States